- Earlier this year, IDACORP reported first-quarter 2026 earnings that exceeded expectations with earnings per share of US$1.21 on revenue of US$477.76 million, and entered an equity distribution agreement to issue up to US$600 million of common stock through at-the-market offerings.
- This combination of stronger-than-expected results and fresh equity capacity underscores how IDACORP is funding grid and generation investments amid rising electricity demand.
- With the new US$600 million at-the-market equity program in place, we’ll examine how this development could reshape IDACORP’s investment narrative.
Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
IDACORP Investment Narrative Recap
To own IDACORP, you need to believe that regulated returns on a growing rate base will offset weather and regulatory risks as demand rises. The recent earnings beat and new US$600,000,000 at the market equity program support near term grid and generation spending, but also sharpen the short term risk that heavier equity issuance could dilute per share returns if capital recovery or load growth disappoint.
The most relevant recent announcement is the US$600,000,000 at the market common stock program, which adds to IDACORP’s existing pattern of follow on equity raises. This additional capacity directly ties into the key catalyst of large scale transmission and generation investments, while also intersecting with the financing risk that regulators might not fully approve cost recovery on an expanding capital base.
Yet behind IDACORP’s strong share price, investors should still be aware of how increased equity issuance could affect...
Read the full narrative on IDACORP (it's free!)
IDACORP's narrative projects $2.4 billion revenue and $506.8 million earnings by 2029. This requires 10.7% yearly revenue growth and about a $175 million earnings increase from $331.8 million today.
Uncover how IDACORP's forecasts yield a $153.00 fair value, in line with its current price.
Exploring Other Perspectives
Four fair value estimates from the Simply Wall St Community span about US$112 to US$153 per share, showing how far apart individual views can be. As you weigh these perspectives against IDACORP’s heavy capital needs and regulatory approval risks, it is worth exploring several alternative viewpoints before deciding how this stock fits into your portfolio.
Explore 4 other fair value estimates on IDACORP - why the stock might be worth as much as $153.00!
The Verdict Is Yours
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your IDACORP research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- Our free IDACORP research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate IDACORP's overall financial health at a glance.
Seeking Other Investments?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- Find 44 companies with promising cash flow potential yet trading below their fair value.
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com